The event will provide a platform to pharmaceutical companies to showcase their latest, best and innovative products / services along with modular conference and panel discussions. The event has participation from 790 exhibitors from 18 countries and regions and over 25000 trade visitors are expected to attend the three-day event. Companies from India, China, Japan, Germany, Taiwan, USA, France, Canada, UK, UAE, Korea, Belgium, The Netherlands, Czech Republic, Italy, Israel, Singapore, Switzerland will participate in the event.
Informing about last year’s success of the event, Sanjeev Khaira, Managing Director, UBM India, said, “Attendee numbers in 2009 hit 26,303 from 86 countries, of which 2,495 were international visitors. According to our visitor survey, 91% of CPhI India 2009 visitors rated CPhI India events either good or excellent and 89% visitors showed willingness of visiting CPhI India 2010.”
According to Daara B Patel, Secretary General, Indian Drug Manufacturers' Association (IDMA), “India is on the leading edge of the pharma market, with the domestic growth at a healthy 13% in 2009 and a spectacular growth of over 25% in exports, much higher than the global average. This growth is expected to continue its upward trend as the world increasingly depends on Indian generics and rightly so, IDMA’s theme for the year has been ‘India – The Generics Pharma Capital of the World’. In line with this development also is the Indian pharmaceutical machinery and equipment market, which is growing at an average of 15-20% per year.”
Smitesh Shah, Chairman, Pharmexcil, said, “The Domestic pharma sector has been expanding and estimated at US$ 11.72 billion (Rs 55454 crore) in 2008-09 from US$ 6.88 billion (Rs 32575 crore) in 2003-04. Indian pharma exports have been consistently growing in the range of 8 to 12 per cent over past 6-7 years. Indian exports are destined to various countries around the globe including highly regulated markets of USA, Europe, Japan and Australia. The events like, CPhI will certainly bring Indian industry leaders on wider international platform and business opportunities.”
“The three-day event this year, will also have a conference on trends and various issues pertaining to the advanced API strategies, super Generics trends & opportunities, exporting hot-spots & strategies, drug discovery in India, commercializing biosimilars, vaccine product opportunities, nanotechnology applications, commercializing stem cells, oncology pipeline trends, gearing up CRAM infrastructure, NDDS platform developments, cost-effective high-yield machinery etc,” added Mr Sanjeev Khaira.
The flagship exhibition CPhI India will include companies dealing with Active Pharmaceutical Ingredients and allied products. The concurrent event P-MEC India 2010 will give an unprecedented insight into the future of pharmaceutical equipment and machinery. The event will highlight latest knowledge and trends in the industry. It is the best place for you to source quality machinery and equipments at competitive prices.
The International Contract Services Expo (ICSE) will focus on sourcing strategic partnerships for the pharmaceutical companies throughout the world that would have the best strategic fit with their own organisation. These developments have underlined the need for a global meeting place for the pharmaceutical industry which is to be addressed at the ICSE during the event.
Bio Solutions is an emerging trend in the pharmaceutical sector as an altogether unique segment. It has become the innovate engine for the pharmaceutical industry as a whole and hence, BioPh will create a conducive environment and platform for the industry players at the event.
All the co-located events will offer a global platform for buyers and sellers from Pharma industry to enhance their business prospects, to establish strategic alliances, technology transfer etc. Showcasing a platform of international standards, the event will pave the way for intra-industry cooperation and will bridge the gap between international community and Indian enterprises while exploring bigger business avenues and showcase Indian Pharma Industry as the emerging global sourcing hub of Pharma.
